Results 251 to 260 of about 90,432 (374)
Innate Immunity: Cytoplasmic DNA Sensing by the AIM2 Inflammasome
Kate Schroder +2 more
openalex +1 more source
Inflammasome-Dependent Release of the Alarmin HMGB1 in Endotoxemia [PDF]
Mohamed Lamkanfi +8 more
openalex +1 more source
Serum cytokine profiling differentiates underlying diseases in cytokine storm syndrome
Objective Cytokine storm syndrome (CSS), commonly associated with hemophagocytic lymphohistiocytosis (HLH), is a fatal hyperinflammatory syndrome. Differentiating the underlying diseases responsible for CSS is essential for timely therapeutic decisions. This study explored the clinical usefulness of serum cytokine profiling in distinguishing underlying
Shuya Kaneko +42 more
wiley +1 more source
Research progress on microglial pyroptosis and inflammasomes: a comprehensive analysis. [PDF]
Wang X, Li Z, Ma B, Jia Q.
europepmc +1 more source
Objectives Giant cell arteritis (GCA) is a large‐vessel vasculitis, potentially causing complications such as blindness and strokes. This study aims to gain insights into the pathogenesis of GCA by identifying specific DNA methylation signatures in the arterial tissue of patients with this vasculitis.
Gonzalo Borrego‐Yaniz +18 more
wiley +1 more source
Chemical probing reveals insights into the signaling mechanism of inflammasome activation [PDF]
Yi‐Nan Gong +8 more
openalex +1 more source
Background Gout due to the formation of monosodium urate (MSU) crystals and calcium pyrophosphate (CPP) deposition disease are two major types of microcrystalline pathologies in adults. They are responsible for recurrent flares that rely on interleukin (IL)‐1β via activation of the NLRP3 inflammasome.
Chinh Nghia Pham +15 more
wiley +1 more source
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi +8 more
openalex +2 more sources
Objectives The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS syndrome. Methods This multicenter international study includes VEXAS patients from France, Israel, and Italy treated with IL1 inhibition (IL1i).
Tali Eviatar +35 more
wiley +1 more source

